Maina Bhaman
Partner
Works at Sofinnova
Investor profile | Builders Republic
About
Partner at Sofinnova, Maina Bhaman invests from pre-seed to growth with check sizes ranging from €1 to €60 million, particularly in agri-food, healthcare and life sciences, and electronics and telecommunications. A partner at Capital Strategy since 2018, she or he was previously Director of Healthcare Investment at Touchstone Innovations (London), after roles in R&D at Celltech and Oxford GlycoSciences. Her or his track record includes Catamaran Bio, CinCor Pharma, ENYO Pharma, and Myricx Bio. Education: BSc University of Texas at Austin, MBA Imperial College.
Profile
- Role
- Partner
- Fund
- Sofinnova